Scientific American’s take on reducing readmissions through cutting-edge technology

One in five Medicare patients return to the hospital within a month after discharge, so it isn’t surprising that the federal government is pushing forward an agenda to discourage costly readmissions. Come October, hospitals with chronic readmission problems with patients struggling with heart failure, pneumonia and heart attack will face Medicare reimbursement penalties.

With this federal pressure on the horizon, an April 9 Scientific American article delves into all the promising technology—such as telehealth and mobile devices, microchipped medications and accessible digital health records—that could keep patients and physicians connected post discharge and bring down expensive readmissions in the process.

Around the web

A string of executive orders from the White House created serious concerns among radiologists and other healthcare providers throughout the United States. The American College of Radiology issued a statement to help guide its members through the chaos. 

Bridgefield Capital, founded in 2015, has previously invested in such popular brands as Cirque Du Soleil, Del Monte and Quiksilver. This transaction is expected to be completed in the second half of 2025. 

Given the precarious excitement of the moment—or is it exciting precarity?—policymakers and healthcare leaders must set directives guiding not only what to do with AI but also when to do it.